Wall Street brokerages predict that Anthem Inc (NYSE:ANTM) will post $23.33 billion in sales for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Anthem’s earnings, with the lowest sales estimate coming in at $22.85 billion and the highest estimate coming in at $23.64 billion. Anthem posted sales of $22.45 billion in the same quarter last year, which would indicate a positive year over year growth rate of 3.9%. The business is expected to announce its next quarterly earnings report on Wednesday, January 30th.
According to Zacks, analysts expect that Anthem will report full year sales of $91.64 billion for the current year, with estimates ranging from $90.88 billion to $92.17 billion. For the next fiscal year, analysts expect that the company will report sales of $98.27 billion, with estimates ranging from $96.33 billion to $100.07 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow Anthem.
Anthem (NYSE:ANTM) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $3.81 earnings per share for the quarter, beating analysts’ consensus estimates of $3.70 by $0.11. The company had revenue of $22.98 billion for the quarter, compared to analyst estimates of $22.85 billion. Anthem had a return on equity of 13.99% and a net margin of 4.98%. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.65 EPS.
A number of brokerages recently issued reports on ANTM. Credit Suisse Group raised their price objective on Anthem from $284.00 to $311.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 4th. Morgan Stanley raised Anthem from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $273.00 to $368.00 in a research report on Wednesday, September 5th. Citigroup downgraded Anthem from a “buy” rating to a “neutral” rating and set a $162.00 target price for the company. in a research report on Monday, September 10th. Cowen initiated coverage on Anthem in a research report on Monday, September 17th. They set an “outperform” rating and a $318.00 price objective for the company. Finally, Jefferies Financial Group reissued a “buy” rating and set a $316.00 price objective on shares of Anthem in a research report on Friday, October 12th. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $300.33.
In related news, Director Julie A. Hill sold 500 shares of the business’s stock in a transaction that occurred on Thursday, November 8th. The stock was sold at an average price of $287.25, for a total transaction of $143,625.00. Following the completion of the sale, the director now owns 34,327 shares in the company, valued at $9,860,430.75. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Peter D. Haytaian sold 4,500 shares of the business’s stock in a transaction that occurred on Tuesday, November 27th. The stock was sold at an average price of $278.48, for a total value of $1,253,160.00. Following the sale, the executive vice president now owns 47,006 shares of the company’s stock, valued at approximately $13,090,230.88. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,826 shares of company stock valued at $5,815,620. Corporate insiders own 0.31% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Anthem by 2.9% during the third quarter. Vanguard Group Inc. now owns 18,729,474 shares of the company’s stock worth $5,132,811,000 after purchasing an additional 532,579 shares during the last quarter. Alliancebernstein L.P. lifted its stake in Anthem by 0.3% during the third quarter. Alliancebernstein L.P. now owns 2,958,593 shares of the company’s stock worth $810,802,000 after purchasing an additional 7,671 shares during the last quarter. OppenheimerFunds Inc. lifted its stake in Anthem by 5.2% during the third quarter. OppenheimerFunds Inc. now owns 2,537,684 shares of the company’s stock worth $695,452,000 after purchasing an additional 125,203 shares during the last quarter. Lyrical Asset Management LP lifted its stake in Anthem by 1.9% during the third quarter. Lyrical Asset Management LP now owns 1,875,767 shares of the company’s stock worth $514,054,000 after purchasing an additional 35,731 shares during the last quarter. Finally, Artisan Partners Limited Partnership lifted its stake in Anthem by 40.2% during the second quarter. Artisan Partners Limited Partnership now owns 1,788,388 shares of the company’s stock worth $425,690,000 after purchasing an additional 512,962 shares during the last quarter. Hedge funds and other institutional investors own 87.12% of the company’s stock.
Shares of NYSE ANTM traded down $6.88 during trading on Wednesday, hitting $280.53. 1,675,489 shares of the company were exchanged, compared to its average volume of 1,329,885. Anthem has a 12-month low of $215.52 and a 12-month high of $300.57. The company has a quick ratio of 1.54, a current ratio of 1.53 and a debt-to-equity ratio of 0.59. The firm has a market cap of $74.34 billion, a PE ratio of 23.30, a P/E/G ratio of 1.40 and a beta of 0.85.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 21st. Stockholders of record on Wednesday, December 5th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date is Tuesday, December 4th. Anthem’s dividend payout ratio is presently 24.92%.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Recommended Story: Closed-End Mutual Funds (CEFs)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.